Daily Judi: Wednesday, November 16, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
The U.S. Food and Drug Administration published the guidance, “Multiple Endpoints in Clinical Trials,” created to detail how to use secondary endpoints in clinical trials to show efficacy. (Lexology)
Daryl Lovell interviews Katherine McDonald, of Syracuse University, on including adults with intellectual disability in clinical trials, and the roles federal agencies can play. (Syracuse University News)
New studies suggest COVID-19 rebound after treatment with Paxlovid is more common than previously known. (CNN)
The CNS Summit 2022 begins tomorrow, and runs November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team AG Mednet will be there!
Our Culture
“Dossiers and redaction are built within the Judi platform, which helps significantly with adjudication management—and the client collaborates on the process.”
–Jess, Program Manager
About Judi
Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.
